PFG
50
-2
AMZN
59
3
HAL
62
-2
MSFT
57
6
WHR
65
-7
URI
73
5
DRI
57
-3
AMGN
31
-16
BLK
61
-2
GS
78
3
HST
59
7
PYPL
56
-4
STZ
52
-5
NVDA
54
2
GM
65
-7
KHC
20
2
UPS
61
-3
GME
70
2
CVS
52
-6
FLR
56
-2
PFG
50
-2
AMZN
59
3
HAL
62
-2
MSFT
57
6
WHR
65
-7
URI
73
5
DRI
57
-3
AMGN
31
-16
BLK
61
-2
GS
78
3
HST
59
7
PYPL
56
-4
STZ
52
-5
NVDA
54
2
GM
65
-7
KHC
20
2
UPS
61
-3
GME
70
2
CVS
52
-6
FLR
56
-2
Financhill
Back

Adverum Biotechnologies Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
38

ADVM
Adverum Biotechnologies

Last Price:
6.16
Seasonality Move:
22.26%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
130.47
Seasonality Move:
14.88%
Sell
38
Adverum Biotechnologies (ADVM) is a Sell

Is Adverum Biotechnologies a Buy, Sell or Hold?

  • The current Adverum Biotechnologies [ADVM] share price is $6.16. The Score for ADVM is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • ADVM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ADVM Stock Price Chart

What is Adverum Biotechnologies's stock price today?

  • The Adverum Biotechnologies share price today is $6.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADVM is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

ADVM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.43 Sell
Relative Strength Index (14 RSI): 33.77 Sell
Chaikin Money Flow: 84445 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.54 - 8.04) Sell
Bollinger Bands (100): (6.68 - 8) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

ADVM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.28 Sell
20-day SMA: 7.12 Sell
50-day SMA: 7.35 Sell
200-day SMA: 9.7 Sell
8-day EMA: 6.37 Sell
20-day EMA: 6.89 Sell
50-day EMA: 7.23 Sell
200-day EMA: 8.72 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Adverum Biotechnologies Earnings Growth & ADVM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.56 per share, and an increase next year of $0.34 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Adverum Biotechnologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):